Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease: a Prospective Single-center Randomized Non-inferiority Trial

NCT05334095 is registered in ClinicalTrials.gov with Xiongjing Jiang as lead sponsor.

NCT NCT05334095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05334095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease: a Prospective Single-center Randomized Non-inferiority Trial
Lead sponsor
Xiongjing Jiang
Phase
Not applicable
Overall status
Unknown status
Start date
August 20, 2019
Completion date
September 1, 2022
Enrollment
1,062 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous intervention via femoral artery, peripheral vascular diseases